Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02272959|
Recruitment Status : Recruiting
First Posted : October 23, 2014
Last Update Posted : September 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Anxiety Disorders||Behavioral: Attention bias modification treatment (ABMT) Behavioral: Attention Control Condition||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Attention Bias Modification Treatment for Children With Anxiety Disorders Who do Not Respond to Cognitive Behavioral Therapy: A Randomized Controlled Trial|
|Study Start Date :||January 2015|
|Estimated Primary Completion Date :||July 2019|
|Estimated Study Completion Date :||July 2019|
Experimental: Attention Bias Modification treatment (ABMT)
Attention training via repeated trials of a dot-probe task intended to direct attention away from threat stimuli using threat and neutral stimuli.
Behavioral: Attention bias modification treatment (ABMT)
Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns using threat and neutral stimuli.
Placebo Comparator: Placebo Group
Attention training via repeated trials of a dot-probe task not intended to change threat-related attention patterns using only neutral stimuli.
Behavioral: Attention Control Condition
Attention training using a computerized spatial attention task (dot-probe) not intended to alter threat-related attention patterns using only neutral stimuli.
- The Pediatric Anxiety Rating Scale (PARS) [ Time Frame: expected average time frame of 6 weeks. ]The PARS assesses global anxiety severity across different anxiety disorders in youth.
- Anxiety Related Emotional Disorders - Child/Parent Version (SCARED-C/P) [ Time Frame: expected average time frame of 6 weeks. ]
The SCARED is a 41-item self and parent-report instrument designed to assess anxiety in children and adolescents.
Screen for Child
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02272959
|Contact: Yair Bar-Haim, Prof.||email@example.com|
|Contact: Marian Linetzky, M.A.||firstname.lastname@example.org|